News

News

Incretin Hormones: A New Avenue Against Diabetes

In this article, Dr. Wiam I. Hussein discusses the promising potential of incretin hormones as a novel approach in the fight against type 2 diabetes. The article emphasizes the importance of GLP-1 mimetics and DPP-4 inhibitors, highlighting their role in improving postprandial blood glucose levels and overall glycemic control. The development of these new therapeutic agents represents a significant advancement in diabetes management, offering hope for more effective and less invasive treatments. The article underlines the growing interest in these agents, either as standalone treatments or in combination with other therapies, to address the increasing burden of type 2 diabetes.